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Abstract 
 Macrophages are predominant drivers of inflammation during an acute 
inflammatory response.  Pro-inflammatory mediator production induced by pathogen-
associated molecular patterns (PAMPs) can have profound physiological consequences 
manifesting disease states such as acute lung injury (ALI) and sepsis.  Macrophages 
can assume two distinct phenotypes defined by differential expression patterns and 
immune functions [1].  An M1 phenotype activated by lipopolysaccharide (LPS) is 
characterized by the expression and secretion of pro-inflammatory cytokines, whereas 
an M2 phenotype is more anti-inflammatory and associated with wound healing [1].  
While the role of catecholamines in regulating various physiological functions has been 
extensively studied, there is accumulating evidence suggesting that they may also play 
a pivotal role in regulating immune responses.  In this study, we describe the ability of 
catecholamines to skew LPS-induced M1 macrophages to an M2 phenotype through 
the modulation of TLR4 signaling and regulation of phagocytosis.  This occurred via a 
non-canonical 2 adrenergic receptor signaling pathway and the downstream activation 
of phosphoinositide 3-kinase (PI3K).  Mice which received a 2  adrenergic receptor 
antagonist prior to the induction of ALI or sepsis demonstrated more M1-like responses, 
and their survival was severely attenuated.  Altogether, our results suggest a role for the 
engagement of catecholamines with the 2 adrenergic receptor to induce an M2 
phenotype during inflammation in vivo.                        
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Introduction 
 The scientific discipline of immunology can be unambiguously divided into two 
distinct yet intrinsically connected categories, innate and adaptive immunity.  These two 
immunological arms work in coordination to provide both immediate and long-term 
immunity to various pathogens.  Although adaptive responses, mediated predominately 
by B and T lymphocytes, provide a specific and sustained response to antigens through 
the secretion of antibodies and the employment of apoptosis-inducing mechanisms, 
effective responses require approximately 5 days following primary lymphocyte 
activation.  Thus, the immune responses demonstrated in the early stages of 
pathogenic challenge are dependent upon innate inflammatory cells, most commonly 
neutrophils, macrophages, and dendritic cells.  While different pathogens elicit different 
responses, macrophages are the main drivers of inflammation when activated by 
virulent motifs (pathogen-associated molecular patterns, PAMPs) specific to bacterial 
endotoxins and viral RNA, among other molecules.  Upon stimulation, macrophages 
coordinate subsequent immune responses through the secretion of cytokines and 
chemokines, the phagocytosis of foreign cells and immune complexes, and the 
presentation of antigen to T lymphocytes.   
 The cytokines and chemokines secreted by macrophages and other immune 
cells serve a variety of functions.  In the context of an infection, pro-inflammatory 
cytokines (e.g., tumor necrosis factor (TNF)- and interleukin (IL)-1) act as 
endogenous pyrogens to induce fever while acting on the vascular endothelium to 
increase the rate of immune cell extravasation.  Systemic infections (i.e., sepsis) 
generate robust amounts of circulating TNF- and IL-1, and in consequence, they can 
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induce fever, severe hypotension, and multi-organ failure.  Conversely, anti-
inflammatory cytokines (e.g., IL-10) suppress these pro-inflammatory pathways to limit 
physiological harm.  In addition, smaller secreted ligands known as chemokines can be 
released from macrophages to induce the chemotaxis of additional immune cells 
towards sites of infection in a concentration-dependent fashion.  While these pathways 
are all characteristic of an immediate reaction to pathogens, another important function 
of the cytokines released during the acute phase of an infection is to coordinate a 
subsequent adaptive immune response, in conjunction with the presentation of antigen 
to helper T lymphocytes.   
 The interface between innate and adaptive immunity is critical in mounting an 
appropriate and effective response to foreign specimens.  While the clearance of some 
pathogens may require cell-mediated, inflammatory pathways, others may be best 
combated through the employment of humoral strategies that are characterized by a 
lack of inflammation.  The two predominant cell types responsible for the immune 
system committing to one pathway or the other are Th1 and Th2 helper T lymphocytes.  
More specifically, Th1 inflammatory T cells serve as facilitators of inflammation through 
the activation of cytotoxic T lymphocytes, natural killer cells, macrophages, and 
neutrophils, whereas Th2 helper T cells promote B lymphocyte activation leading to the 
production and secretion of antibodies used to neutralize and target pathogenic 
antigens for immune uptake and destruction.  Upon the activation of helper T cells by 
antigen presentation, the surrounding cytokine environment is pivotal for determining 
which of these two cell types will dominate in the ensuing response.  Specifically, it has 
been well documented that IL-10, for example, is known to promote Th2 T cell 
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differentiation while inhibiting Th1 T cell differentiation [1].  Conversely, IL-12 has been 
shown to promote a Th1 T cell phenotype while inhibiting Th2 T cell differentiation [1].  
Thus, the cytokines produced by macrophages during acute inflammation largely 
influence the nature of subsequent adaptive responses. 
 Central to the crosstalk between innate and adaptive immunity are the pattern 
recognition receptors (PRRs), which are expressed on cells of the innate immune 
system.  This family of receptors includes the Toll-like receptors, NOD-like receptors, 
RIG-I-like RNA helicases, and C-type lectin receptors.  Unlike T and B cell receptors, 
which specifically recognize and bind to protein epitopes, PRRs become activated by 
particular motifs inherent to various pathogens.  One PRR that has been extensively 
studied in the context of gram-negative bacterial infections is the Toll-like receptor 4 
(TLR4).  As a transmembrane protein receptor, TLR4 binds to an endotoxin, 
lipopolysaccharide (LPS), which is present on the outer cell wall of gram-negative 
bacteria.  This ligand-receptor interaction activates an intracellular signaling cascade 
leading to the downstream nuclear translocation of a transcription factor, NF-B, which 
is responsible for the expression of pro-inflammatory cytokines.  How various 
extracellular mediators regulate this pathway has been under extensive investigation in 
recent years. 
 Activated macrophages can be broadly classified as exhibiting either an M1 or 
M2 phenotype.  Whereas M2 macrophages are known to be functionally more anti-
inflammatory, M1 macrophages have been shown to readily produce pro-inflammatory 
cytokines (e.g., IL-12(p40) and TNF-), anti-microbial reactive oxygen species, and 
nitrogen intermediates [1,2].  More specifically, the synthesis of nitric oxide by iNOS is a 
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well-documented pathway characteristic of M1 macrophages [3].  As a result, the M1 
macrophage phenotype is a potent inducer of Th1 inflammatory T cell responses and 
tissue damage [1].  Referred to as being classically activated, the M1 phenotype can be 
elicited through the activation of TLR4 by LPS [1].   
 Conversely, M2 macrophages are comprised of a collection of phenotypes that 
can be non-classically activated via stimulation by type 2 cytokines, such as IL-4, IL-10, 
and IL-13, and glucocorticoid hormones [4].  The M2 phenotype is characterized by the 
suppressed production of pro-inflammatory cytokines and chemokines, and thus, these 
macrophages are known to promote Th2-mediated, anti-inflammatory responses [4].  In 
addition, while M1 macrophages express high levels of iNOS, M2 macrophages are 
known to highly express arginase-1 [5].  Both enzymes compete for the same substrate, 
L-arginine, and as a result, their reciprocal regulation can be used to effectively define 
the M1 and M2 phenotypes [5].  The arginase-1-mediated pathway confers M2 
macrophages with wound-healing capacities through the induction of angiogenesis and 
fibrosis [6].  Whereas all M2 macrophages possess these general characteristics, recent 
work has further classified the M2 phenotype based on disparities in the etiology of 
activation and subsequent functional differences [1].  Identifiable by specific surface 
markers, M2a (alternatively activated) macrophages can be induced through their 
exposure to IL-4 and IL-13 [7,8].  Another M2 phenotype, the regulatory macrophage, 
can be elicited by exposure to IgG immune complexes (M2b subtype) or IL-10 (M2c 
subtype) [1,9].  Regulatory macrophages differ from alternatively activated 
macrophages by their enhanced production of IL-10 and augmented phagocytic activity 
[9].  Given the vast differences in the function of M1 and M2 macrophages during 
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infection, understanding how various environmental factors influence their plasticity is of 
great importance in science and medicine. 
 While neuroendocrine hormones (e.g., catecholamines) have been extensively 
studied in the context of various physiological systems, there is emerging evidence for 
their role in regulating both acute and chronic immune responses.  Specifically, it has 
been shown that catecholamines are upregulated in vivo during inflammatory conditions 
[10].  Various  adrenergic receptor agonists have also been shown to modulate 
cytokine production pathways in vitro [11-14].  Our lab recently published a study 
illustrating that in addition to their bronchodilating effects, synthetic 2 adrenergic 
receptor agonists are able to suppress macrophage pro-inflammatory cytokine 
production both in culture and during experimental acute lung injury (13).  Given these 
findings, we hypothesized that, like their synthetic analogs, catecholamines may engage 
with the 2 adrenergic receptor to modulate TLR4 signaling in macrophages not only to 
suppress an M1 phenotype, but also to induce M2-like responses in vivo during acute 
inflammation. 
 In this study, we report that epinephrine and norepinephrine activate the 2 
adrenergic receptor both in vitro and in vivo to modulate TLR4-mediated macrophage 
cytokine and phenotype marker expression.  While LPS-stimulated M1 macrophages 
demonstrate strong pro-inflammatory responses, macrophages stimulated with LPS in 
the co-presence of catecholamines exhibit an M2 regulatory macrophage phenotype 
with enhanced IL-10 and arginase-1 expression and augmented phagocytic activity.  In 
vivo, mice administered a 2 adrenergic receptor antagonist had severely exacerbated 
acute lung injury characterized by increased pro-inflammatory cytokine production in the 
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lung.  In addition, the survival of endotoxemic mice administered the same inhibitor was 
significantly compromised.  Importantly, M2 macrophages polarized by catecholamines 
in vitro were protective when adoptively transferred during experimental endotoxemia.  
Altogether, these results suggest a protective role for catecholamines in vivo in 
promoting an M2, anti-inflammatory macrophage phenotype.              
 
Methods 
Animals 
Procedures performed in this study were all in accordance with the U.S. National 
Institutes of Health guidelines and were approved by the University of Michigan 
Committee on the Use and Care of Animals.  All experiments were performed in male, 
age-matched C57BL/6 mice (10-12 weeks old) purchased from Jackson Laboratories 
(Bar Harbor, ME, USA) housed in pathogen-free conditions.  TRIF-/- and MyD88-/- mice 
on the C57BL/6 background were also purchased from Jackson Laboratories.  
 
Isolation of Peritoneal Macrophages 
Elicited peritoneal macrophages were harvested 4 days following the intraperitoneal 
(i.p.) injection of 2.4% thioglycollate (Life Technologies, Grand Island, NY, USA).  Cells 
were cultured in RPMI 1640 media (Life Technologies) containing 100 U/ml penicillin-
streptomycin and 0.1% bovine serum albumin, and purification was achieved via culture 
plate adherence.  Cell-free supernatants were stored at -80C until later use.  In vitro 
experiments contained triplicate samples (1 x106 cells per sample) replicated over at 
least 2 independent experiments. 
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Enzyme-linked immunosorbent assays (ELISA) 
Albumin ELISAs were supplied by Bethyl Laboratories (Montgomery, TX, USA).  
Detection of mouse IL-10, TNF-, and IL-12(p40) was achieved with sandwich ELISAs 
(kits were purchased from R&D Systems – Minneapolis, MN, USA).  All protocols were 
performed according to the manufacturer’s recommendations.  Cytokine concentrations 
were determined from log-transformed standard concentrations plotted on a standard 
curve.  
 
Real-Time PCR 
Total RNA was isolated from cultured cells using TRIzol (Sigma-Aldrich, St. Louis, MO, 
USA).  Following purification, DNAse (Life Technologies) was used to remove any 
genomic DNA.  cDNA was generated using the reverse transcription kit provided by Life 
Technologies and RT-PCR (SYBR, Life Technologies) was performed on a 7500 real-
time PCR system (Applied Biosystems, Foster City, CA, USA).  The following primers 
were used:  
GAPDH Fwd: 5’ CTTCAACAGCAACTCCCACTCTTCC 3’  
GAPDH Rev: 5’ GGTGGTCCAGGGTTTCTTACTCC 3’  
IL-10 Fwd: 5’ CCAGTTTTACCTGGTAGAAGTGATGCC 3’  
IL-10 Rev: 5’ GTCTAGGTCCTGGAGTCCAGCAGAC 3’   
TNF- Fwd: 5’ CTGAACTTCGGGGTGATCGGTCC 3’  
TNF- Rev: 5’ GTATGAGATAGCAAATCGGCTGACG 3’  
Arginase-1 Fwd: 5’ ATGGAAGAGACCTTCAGCTACCTGC 3’  
Arginase-1 Rev: 5’ GCTGTCTTCCCAAGAGTTGGG 3’   
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iNOS Fwd: 5’ ACATCGACCCGTCCACAGTAT 3’  
iNOS Rev: 5’ CAGAGGGGTAGGCTTGTCTCTGG 3’ 
Relative expression levels were calculated using 2-ddCt method and were normalized to 
GAPDH.   
 
Phagocytosis Assays   
Peritoneal-elicited macrophages (unstimulated, LPS-treated, or LPS and epinephrine 
co-treated) were incubated with pHrodo Green E. Coli Bioparticles (1 mg/ml; Life 
Technologies).  Reactions proceeded for 1 hour.  Flow cytometric analysis was carried 
out on a BD LSR-II flow cytometer equipped with FACSDiva software (both from BD 
Biosciences, San Jose, CA, USA).  More than 5 x104 cells were analyzed from each 
sample and data analysis was performed using FlowJo software (TreeStar, Ashland, 
OR, USA).  
 
Acute Lung Injury 
ALI was induced via the intratracheal (i.t.) injection of LPS as previously described [13].  
Following a medial thoracic incision performed under anesthesia with ketamine, mice 
received 60 g of LPS from E. coli (o111:B4; Sigma-Aldrich) in a volume of 30 l saline 
solution.  Sham control mice received an equivalent volume of sterile saline.  
Bronchoalveolar lavage fluids were collected via the instillation and retraction of sterile 
PBS into the lung.  For studies involving ICI 118, 551 (Sigma-Aldrich), the small 
molecule inhibitor was administered at 25 mg/kg i.p. 1 hour prior to LPS administration 
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and 6 ng i.t. during the induction of ALI.  Vehicle controls received equivalent volumes 
of sterile saline solution. 
 
Endotoxemia 
Mice received either 10 mg/kg or 20 mg/kg body weight i.p. injection of 
lipopolysaccharide (LPS) from E. coli (o111:B4; Sigma-Aldrich).  Plasma was harvested 
by bleeding from the retro-orbital venous plexus under isoflurane anesthesia.  500 g of 
ICI 118,551 (Sigma-Aldrich) was administered i.p. to achieve 2 adrenergic receptor 
blockade.  For adoptive transfer experiments, thioglycollate-elicited peritoneal 
macrophages were treated in vitro with LPS in the presence or absence of epinephrine 
for 1 hour prior to administration.  Treated or untreated macrophages were harvested, 
washed, and injected i.p. at 1 x106 cells in 200 l of PBS with the induction of 
endotoxemia (20 mg/kg) occurring 4 hours later. For survival studies, mice were 
monitored at least every 12 hours for 7 days.  
 
Statistical Analysis 
Data in this study (values expressed as mean ± SEM) were analyzed using GraphPad 
Prism 6 graphing and statistical analysis software (GraphPad Inc., La Jolla, CA, USA).  
Significance between sample means was determined by an unpaired, two-tailed 
Student’s t test.  Survival study data were analyzed by Log-rank (Mantel-Cox) tests.  
Differences were considered significant when the p value was less than 0.05. 
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Reagents 
Epinephrine, norepinephrine, ICI 118,551, U0126, SP600125 (all from Sigma, St. Louis, 
MO, USA), 2’, 5’-dideoxyadenosine (2’, 5’-DDA; Santa Cruz Biotech, Santa Cruz, CA, 
USA), SQ22536 (Santa Cruz Biotech), PKA inhibitor 14-22 amide (EMD Millipore, 
Billerica, MA, USA), wortmannin (Santa Cruz Biotech), were all used at concentrations 
indicated in each figure.  LPS (E. coli o111:B4) was purchased from Sigma.  Optimal 
concentrations for these reagents were determined in preliminary experiments.    
 
Results 
Catecholamines modulate TLR4-induced macrophage cytokine production via activation 
of the 2 adrenergic receptor  
 
 To illustrate whether catecholamines could regulate cytokine production 
pathways in vitro, peritoneal-elicited macrophages from wild-type mice were incubated 
for 4 hours with LPS alone or LPS in the co-presence of epinephrine or norepinephrine. 
Results showed that both adrenergic receptor agonists influenced cytokine production in 
elicited cells.  Specifically, macrophages stimulated with either catecholamine in the co-
presence of LPS demonstrated attenuated production of the pro-inflammatory cytokine, 
TNF-, and enhanced production of the anti-inflammatory cytokine and Th2 T cell 
activator, IL-10 (Fig. 1A and 1B).  Epinephrine and norepinephrine modulated the 
production of these two cytokines in a dose-dependent fashion with IC50s of 
approximately 5 nM and 700 nM respectively.  Additionally, RT-PCR was used to 
illustrate the regulation of IL-10 and TNF- at the transcriptional level following the co-
activation of TLR4 and the adrenergic receptors via stimulation with catecholamines.  
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Specifically, decreases in supernatant TNF- protein levels were accompanied by a 
suppression of TNF- mRNA expression under the same conditions (Fig. 1C).  
Similarly, increases in supernatant IL-10 protein levels following activation of these 
receptors were accompanied by enhanced IL-10 mRNA expression within the cell (Fig. 
1C).  Altogether, these data demonstrated that epinephrine/norepinephrine are able to 
regulate cytokine production pathways in macrophages via transcriptional control.     
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Figure 1.  Catecholamines modulate TLR4-mediated cytokine expression and 
secretion.  A-B) Mouse peritoneal macrophages were stimulated with LPS (100 ng/ml) 
in the absence or co-presence of varying concentrations of epinephrine or 
norepinephrine for 4 hours.  Culture supernatant cytokine concentrations were 
determined by ELISA.  A) TNF- (left panel) and IL-10 (right panel) dose response 
curves for epinephrine.  B) TNF- (left panel) and IL-10 (right panel) dose response 
curves for norepinephrine.  C) Relative expression of mRNA transcripts for TNF- (left 
panel) and IL-10 (right panel) (RT-PCR). Mouse peritoneal macrophages were 
stimulated with LPS (100 ng/ml) in the absence or co-presence of epinephrine or 
norepinephrine (10-6 M) for 18 hours.  *P<0.05, **P<0.01, ***P<0.001, ****P<0.0001. 
 
It is widely accepted that, upon TLR4 activation by LPS in macrophages, both the 
TRIF-dependent and MyD88-dependent intracellular signaling cascades are initiated.  
To illustrate the effect of endogenous catecholamines on both pathways, peritoneal 
elicited macrophages from TRIF-/- and MyD88-/- mice were stimulated with LPS in the 
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absence or co-presence of epinephrine.  Our data indicated that epinephrine modulates 
both the TRIF-dependent and MyD88-dependent signaling pathways (Fig. 2A and 2B).  
Specifically, in a similar fashion to wild-type macrophages (see Fig. 1A), TRIF-/- 
peritoneal macrophages treated with both LPS and epinephrine displayed significantly 
reduced levels of TNF- and increased levels of IL-10 when compared to knockout 
macrophages treated solely with LPS (Fig. 2A).  Similarly, LPS-induced TNF- 
production by MyD88-/- peritoneal macrophages was significantly vitiated upon treatment 
of these cells with epinephrine (Fig. 2B).  Under similar conditions, IL-10 protein levels 
in the supernatants of the MyD88-/- macrophages were undetectable (data not shown). 
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Figure 2.  Catecholamines regulate both the TRIF and MyD88 signaling pathways.  
A-B) Mouse peritoneal macrophages from TRIF-/- or MyD88-/- mice were stimulated with 
LPS (100 ng/ml) in the absence or co-presence of epinephrine (10-6 M) for 4 hours.  A) 
TNF- (left panel) and IL-10 (right panel) supernatant concentrations from TRIF-/- 
macrophages quantified by ELISA.  B) TNF- supernatant concentrations from MyD88-/- 
macrophages as determined by ELISA.  
 
To confirm the importance of 2 adrenergic receptor signaling in this effect, use of 
the selective 2 adrenergic receptor antagonist, ICI 118,551, was employed.  Our data 
showed that blockade of the 2 adrenergic receptor with the small-molecule inhibitor 
negated the effects of the endogenous catecholamines on both IL-10 and TNF- 
production (Fig. 3A).  Additional data illustrated that the regulation of these cytokines 
due to the activation of 2 adrenergic receptors was also dependent upon the 
engagement of TLR4 by LPS (Fig. 3B).  The presence of either endogenous 
catecholamine alone did not influence cytokine expression, but rather, simultaneous 
activation of TLR4 and the 2 adrenergic receptor was required for altered IL-10 and 
TNF- production in macrophages.  Taken together, these data indicated that the 
signaling mechanism resulting from 2 adrenergic receptor activation influences LPS-
induced cytokine release via modulation of both the TRIF-dependent and MyD88-
dependent intracellular signaling pathways.  
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Figure 3.  Modulation of TLR4-mediated cytokine production is dependent upon 
the simultaneous activation of TLR4 and the 2 adrenergic receptor.  A) Peritoneal 
macrophages were stimulated in the absence or presence of LPS (100 ng/ml), 
epinephrine (10-6 M), and/or ICI 118,551 (2 adrenergic receptor antagonist) for 4 hours.  
TNF- (left panel) and IL-10 (right panel) supernatant concentrations quantified by 
ELISA.  B) Peritoneal macrophages were simulated in the presence or absence of 
epinephrine or norepinephrine (10-6 M) for 4 hours. TNF- (left panel) and IL-10 (right 
panel) supernatant concentrations as determined by ELISA.  
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2 adrenergic receptor signaling regulates TLR4-mediated cytokine production 
independent of the canonical pathway with dependence on phosphoinositide 3-kinase 
 
 Historically, it has been widely accepted that 2 adrenergic receptors initiate 
signal transduction pathways via coupling to heterotrimeric G-proteins and subsequent 
interaction of the Gs subunit with adenylate cyclase leading to increased levels of 
cAMP and the activation of protein kinase A (PKA).  Interestingly, we have found that 
the regulation of macrophage cytokine production by catecholamines is independent of 
this classical pathway and our data have suggested dependence on the  subunits.  
Incubation of peritoneal macrophages with the adenylate cyclase inhibitors, 2’,5’-DDA 
and SQ22536, for 1 hour prior to stimulation with LPS and epinephrine had no effect on 
2 adrenergic receptor signaling and its regulation of the TLR4 pathway (Fig. 4A).  
Specifically, our data illustrated that blockade of adenylate cyclase did not significantly 
affect the modulation of IL-10 or TNF- production by epinephrine.  Additionally, 
inhibition of PKA was used to further bolster these findings.  Macrophages pre-
incubated with the PKA inhibitor for 1 hour prior to co-stimulation with LPS and 
epinephrine produced IL-10 and TNF- levels comparable to stimulated samples 
without PKA inhibitor (Fig. 4B).  These findings suggested that the regulation of 
macrophage cytokine production by 2 adrenergic receptor signaling was achieved 
independent of the canonical pathway.  
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Figure 4. 2 adrenergic receptor signaling regulates macrophage cytokine 
production via a non-canonical pathway.  A-B) Peritoneal macrophages were 
incubated with LPS (100 ng/ml) in the absence or co-presence of epinephrine (10-6 M) 
for 4 hours.  A) Macrophages were pretreated with the adenylate cyclase inhibitors, 
2’,5’-DDA (20 M) or SQ22536 (10 M), or a vehicle control 1 hour prior to stimulation.  
TNF- (left panel) and IL-10 (right panel) supernatant concentrations as determined by 
ELISA.  B) PKA activity was inhibited with a PKA inhibitor 14-22 amide (5 M) added 1 
hour prior to stimulation. TNF- (left panel) and IL-10 (right panel) supernatant 
concentrations quantified by ELISA.  
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The TLR4-activated MyD88-dependent signaling cascade includes the mitogen-
activated protein kinases (MAPKs) (p38, MEK1/2, Erk1/2, and Jnk1/2) as well as PI3K 
and Akt among other intracellular mediators.  To better understand the mechanism 
underlying changes in TLR4 signaling via activation of the 2 adrenergic receptor, 
peritoneal-elicited macrophages were stimulated with LPS and epinephrine following a 
1-hour pre-incubation with specific inhibitors of Jnk1/2 (SP600125), MEK1/2 (U0126), 
and PI3K (wortmannin). IL-10 and TNF- protein levels in the supernatants of these 
samples were compared to levels quantified from samples stimulated according to the 
same conditions, but lacking pre-incubation with the inhibitors.  As illustrated in Figures 
5A and 5B, blockade of Jnk1/2 and MEK1/2, via inhibition with SP600125 and U0126 
respectively, did not affect epinephrine-mediated regulation of macrophage IL-10 and 
TNF- production.  Specifically, the magnitude of enhanced IL-10 and suppressed TNF-
 production by epinephrine remained consistent regardless of the inhibitor used.  
Altogether, these data suggested that regulation of TLR4 signaling by endogenous 
catecholamines was largely independent of MAPK signaling.   
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Figure 5.  Catecholamines regulate TLR4 signaling independent of the MAP 
Kinases. A-B) Peritoneal macrophages were incubated with LPS (100 ng/ml) in the 
absence or co-presence of epinephrine (10-6 M) for 4 hours. A) Macrophages were 
pretreated with the Jnk1/2 inhibitor, SP600125 (50 M) 1 hour prior to stimulation.  TNF-
 (left panel) and IL-10 (right panel) supernatant concentrations as determined by 
ELISA.  B) MEK1/2 activity was inhibited with U0126 (50 M) added 1 hour prior to 
stimulation. TNF- (left panel) and IL-10 (right panel) supernatant concentrations 
quantified by ELISA. 
 
 To examine the role of PI3K in this effect, macrophages were incubated with a 
specific inhibitor of this enzyme, wortmannin, prior to stimulation with LPS in the co-
presence of epinephrine.  Interestingly, we demonstrated that inhibition of PI3K with 5 
M wortmannin negated the effects of 2 adrenergic receptor signaling on modulating 
TNF- and IL-10 production (Fig. 6A).  This effect became less marked with decreasing 
concentrations of inhibitor.  Although the impact of the inhibitor on IL-10 production was 
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less drastic, there was still a noticeable decline (~50%) in IL-10 production from LPS 
and epinephrine co-stimulated macrophages incubated with wortmannin in comparison 
to non-inhibited macrophages (Fig. 6A).  These data strongly suggested that 
macrophage cytokine production is mediated by endogenous catecholamines via the 
downstream activation PI3K. 
Figure 6.  Modulation of TLR4 signaling by the 2 adrenergic receptor requires 
downstream activation of PI3K. A) Peritoneal macrophages were stimulated in the 
absence or presence of LPS (100 ng/ml), epinephrine (10-6 M), and/or varying 
concentrations of wortmannin (PI3K inhibitor) for 4 hours.  Cells were pre-treated with 
the inhibitor for 1 hour.  TNF- (left panel) and IL-10 (right panel) supernatant 
concentrations as determined by ELISA.  
 
Catecholamines induce a regulatory macrophage phenotype   
 Macrophages can assume two distinct phenotypes (M1 and M2) characterized by 
variegated cytokine and phenotypic marker expression profiles [1].  Because these 
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specific phenotypes bring about different functional responses, we were interested in 
illustrating the effect of endogenous catecholamines on macrophage polarization.  
Specifically, it is known that each of these phenotypes is characterized by specific 
cellular markers, including arginase-1, an M2 macrophage marker, and iNOS, an M1 
macrophage marker [3,5].  We first studied the effect of epinephrine and norepinephrine 
on macrophage polarization by looking at the transcriptional control of these two genes 
following stimulation with LPS in the co-presence of catecholamines.  As shown in 
Figure 7A, activation of the 2 adrenergic receptor by treatment of macrophages with 
epinephrine or norepinephrine in the co-presence of LPS enhanced arginase-1 
expression and suppressed iNOS expression when compared to LPS treatment alone.  
These data suggested that catecholamines could promote a shift in macrophage 
phenotype from M1 to M2 and may subsequently serve as an immunoprotective agent 
during the inflammatory response.  To bolster our conclusions, we also illustrated the 
effect of epinephrine and norepinephrine on regulating the production of a well-defined 
M1 cytokine, IL-12(p40), which is a potent activator of Th1 inflammatory T cells.  As 
shown in Figure 7B, the production of this LPS-induced cytokine was significantly 
downregulated in the presence of epinephrine and norepinephrine, again suggesting 
that these endogenous ligands act to promote an anti-inflammatory response in 
macrophages upon activation by gram-negative endotoxins. 
 To further characterize this switch in phenotype, we wanted to better illustrate the 
functional changes associated with an anti-inflammatory response induced by 
catecholamines.  Importantly, M2 regulatory macrophages, a subtype of M2 
macrophages, not only release copious amounts of IL-10 but are also known to be 
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veraciously phagocytic [9].  To demonstrate the effect of epinephrine on macrophage 
phagocytosis, we measured the uptake of fluorescently labeled, heat killed E. coli by 
flow cytometric analysis.  Specifically, co-stimulation of macrophages with LPS and 
epinephrine enhanced the ability of macrophages to phagocytose surrounding E. coli 
cells (Fig. 7C).  These data, in conjunction with our cytokine and phenotypic marker 
expression analyses, strongly suggest that catecholamines skew macrophages from an 
LPS-induced M1 phenotype to an M2 regulatory macrophage phenotype through the 
regulation of cytokine expression and phagocytosis. 
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Figure 7.  Catecholamines induce an M2 regulatory macrophage activation 
phenotype.  A-B) Mouse peritoneal macrophages were incubated with LPS (100 ng/ml) 
in the absence or co-presence of epinephrine or norepinephrine (10-6 M) for 18 hours.  
A) RT-PCR was used to determine the relative mRNA transcript expression levels for 
iNOS (left panel) and arginase-1 (right panel).  B) Culture supernatant levels of IL-12(p40) 
quantified by ELISA.  C) MFI, mean fluorescence intensity, was determined by flow 
cytometric analysis of fluorescent E. Coli Bioparticle phagocytosis.  
 
 Because IL-10 has been shown to act as a mediator for paracrine/autocrine 
signaling in macrophages, and our previous data showed that catecholamines 
enhanced IL-10 production by peritoneal macrophages, we were interested to see 
whether IL-10 was acting as an intermediate to regulate arginase-1 and iNOS 
expression.  Using an IL-10 neutralizing antibody, our data indicated some level of 
reliance on the presence of IL-10 for catecholamine-mediated regulation of arginase-1 
and iNOS expression (Fig. 8).  Specifically, macrophages incubated with a neutralizing 
antibody to IL-10, and stimulated with both LPS and epinephrine in tandem, displayed 
increased levels of iNOS expression and decreased levels of arginase-1 expression 
when compared to macrophages that were stimulated according to the same conditions, 
but lacked treatment with the IL-10 neutralizing antibody.  In both cases, the anti-IL-10 
antibody impaired the ability of epinephrine to modulate iNOS and arginase-1 
expression levels, thus suggesting that IL-10 is an essential mediator in the M1 to M2 
regulatory macrophage phenotype shift induced by catecholamines. 
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Figure 8.  IL-10 acts as a mediator for catecholamines to regulate iNOS and 
arginase-1 expression.  Mouse peritoneal macrophages were incubated in the 
presence or absence of LPS (100 ng/ml), epinephrine (10-6 M), and/or anti-IL-10 for 18 
hours.  Relative expression levels for iNOS (left panel) and arginase-1 (right panel) 
were quantified by RT-PCR. 
 
2 adrenergic receptor activation confers protection during acute lung injury (ALI) and 
experimental endotoxemia           
   
 Given the immune modulating effects clearly demonstrated of epinephrine and 
norepinephrine, we next focused on examining the immunoprotective behavior of 2 
adrenergic receptor activation during ALI by using our well-established in vivo LPS-
induced ALI injury model.  Specifically, we compared the levels of TNF-, IL-10, and 
serum albumin found in the bronchoalveolar lavage fluids (BALF) of wild-type mice 
administered either the 2 receptor antagonist, ICI 118,551, or sterile saline solution 
(vehicle control).  Albumin leak into the alveolar space indicates damage to the alveolar 
epithelium and pulmonary vasculature, and as result, it is an effective method for 
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quantifying injury in the lung.  Mice were administered the ICI 118,551 via an i.p. 
injection 1 hour prior to surgery and an i.t. injection of the inhibitor upon the onset of 
ALI.  In these experiments, ALI was induced via the i.t. injection of LPS and the BALF 
were collected after 8 hours.  As shown in Figure 9A, mice having undergone 2 
blockade produced significantly more TNF- in the lung during ALI when compared to 
the vehicle control mice, though surprisingly, no changes in IL-10 levels were observed 
(Fig. 9B).  Additionally, mice receiving the 2 adrenergic receptor antagonist had 
significantly exacerbated ALI as indicated by the increase in albumin leak (Fig. 9C).  
While it is not entirely clear as to why an increase in injury level was not accompanied 
by definitive changes in cytokine production, these data do suggest a protective role for 
the catecholamines in activating the 2 adrenergic receptor during ALI.  Although this 
unexpected result could be due simply to the pharmacokinetics of the 2 adrenergic 
receptor antagonist, another plausible explanation may involve the role of other 
neurendocrine targets in controlling injury severity independent of the mechanism 
provided above.  The confirmation of an alternative pathway will demand further 
investigation.  
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Figure 9.  Activation of the 2 adrenergic receptor is protective during acute lung 
injury.  A-C) ALI was induced by 60 g of LPS i.t. and BALF was harvested after 8 
hours (n ≥ 9 mice per group).  Administration of ICI 118,551 (25 mg/kg i.p. and 6 ng i.t.) 
was used to block the 2 adrenergic receptor.  A) TNF-, B) IL-10, and C) albumin levels 
were determined by ELISA. 
 
To add credence to our mechanism provided concerning the essential role of 
catecholamines in mediating acute inflammation, we decided to broaden our in vivo 
studies to include an experimental endotoxemia model.  For this model, LPS is injected 
directly into the peritoneum to induce a systemic inflammatory response and doses can 
be adjusted to test for lethality.  Because IL-10 is an essential cytokine in negatively 
regulating macrophage and Th1 cell pro-inflammatory responses during sepsis, we 
tested for the effect of 2 adrenergic receptor blockade on IL-10 production during 
experimental endotoxemia.  As shown in Figure 10A, injection of LPS i.p. upregulated 
the levels of IL-10 detected in mouse plasma.  This concentration spiked at 2 hours 
following endotoxin administration and gradually declined over time with a 50% 
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reduction observed after approximately 8 hours (Fig. 10A).  Importantly, administration 
of the ICI 118,551 inhibitor i.p. 1 hour prior to the induction of endotoxemia significantly 
lessened the levels of IL-10 quantified in serum after 1.5 hours with modest reduction 
still observed after 3 hours (Fig. 10B).  These data suggest a role for catecholamines in 
depressing the inflammatory response through the upregulation of IL-10 during sepsis.   
 To substantiate these in vivo findings, we carried out two survival studies 
illustrating the protective role of catecholamines and their activation of the 2 adrenergic 
receptor during endotoxemia.  As shown in Figure 10C, administration of ICI 118,551 
greatly attenuated survival in septic mice when compared to those receiving the vehicle 
control.  While the inhibitor induced a marked effect, it is important to acknowledge its 
non-specific targets.  More specifically, it has been widely documented that the 2 
adrenergic receptor is involved in regulating a number of physiological processes, such 
as cardiac function, vascular permeability, and metabolism, among others.  To 
circumvent these issues, we performed a highly controlled experiment involving the 
adoptive transfer of macrophages during endotoxemia.  Wild-type mice were 
administered previously elicited peritoneal macrophages (unstimulated, LPS pre-
treated, or those stimulated with LPS in the co-presence of epinephrine in vitro) prior to 
the i.p. injection of LPS, and percent survival was measured.  This experimental design 
allowed us to specifically illustrate the effects of catecholamines on inducing a shift in 
macrophage phenotype and their resulting physiological consequences during sepsis.  
As shown in Figure 10D, the adoptive transfer of macrophages pre-treated with LPS in 
the co-presence of epinephrine prior to the onset of endotoxemia greatly enhanced the 
survival of these mice when compared to mice receiving either the LPS-treated or 
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untreated macrophages.  Altogether, this elegant experiment effectively illustrated the 
protective role of catecholamines in skewing macrophages towards an M2, anti-
inflammatory phenotype during acute inflammation induced by the administration of 
gram-negative endotoxins.  This effect is presumably achieved via the induction of a 
M2/Th2-dominated response characterized by a lack of inflammation and subsequent 
tissue damage. 
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Figure 10.  The M2 regulatory macrophage phenotype induced by catecholamines 
is protective during endotoxemia.  A) Serum IL-10 levels quantified by ELISA 
following the i.p. administration of 10 mg/kg body weight LPS (n = 4 mice per group).  B) 
Endotoxemia induced as described in A.  ICI 118,551 administered at 500 g per 
mouse.  Serum IL-10 levels as determined by ELISA.  C) Survival curve following the 
administration of LPS as described in A with or without ICI 118,551 as described in B (n 
≥ 11 mice per group).  D) Macrophages were incubated in vitro with or without LPS (100 
ng/ml) and epinephrine (10-6 M) for 1 hour.  Cultured cells were harvested, washed, and 
transferred to mice.  After 4 hours, endotoxemia was induced using 20 mg/kg body 
weight LPS (n ≥ 8 mice per group).   
 
Discussion 
 It has been shown in previous studies that catecholamines can suppress the 
production of pro-inflammatory cytokines in human blood models [15-17].  The presence 
of epinephrine and norepinephrine at high concentrations specifically inhibited 
endotoxin-induced TNF-, IL-6, and IL-1 production.  In addition, our lab recently 
showed that synthetic 2 adrenergic receptor agonists elicited similar expression profiles 
in macrophages in the context of LPS-induced acute lung injury [13].  In this report, we 
expanded upon these findings to show that while catecholamines do indeed suppress 
pro-inflammatory mediator production, their activation of the 2 adrenergic receptor also 
plays a pivotal role in regulating macrophage phenotype during LPS-induced 
inflammation.  Whereas LPS-stimulated macrophages elicited M1-type responses, 
macrophages stimulated in the co-presence of catecholamines assumed an anti-
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inflammatory phenotype characterized by the production of potent Th2 T cell activators.  
Specifically, co-stimulated macrophages released suppressed levels of IL-12(p40) and 
TNF- along with enhanced levels of IL-10.  In addition, these macrophages displayed 
an M2 regulatory macrophage phenotype defined by the attenuated expression of 
iNOS, potentiated expression of arginase-1, and augmented phagocytic activity.  
Importantly, the enhanced expression of arginase-1 orients its substrate, L-arginine, 
towards the production of cell growth- and fibrosis-promoting mediators [6].  Thus, the 
M2 regulatory macrophage phenotype elicited by catecholamines is more anti-
inflammatory in function with wound-healing capacities.  Altogether, our data provide a 
novel mechanism by which epinephrine and norepinephrine activate the 2 adrenergic 
receptor to exert regulation over macrophage polarization both in vitro and in vivo during 
acute inflammation (summarized in Fig. 11). 
 
 
  
 
 
 
 
 
 
Figure 11.  Summary of the effects of catecholamines on promoting an M2, anti-
inflammatory macrophage phenotype during TLR4-mediated inflammation.   
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Interestingly, the regulation over intracellular TLR4 signaling demonstrated by 
catecholamines did not occur via the activation of a canonical 2 adrenergic receptor 
signaling pathway.  Rather, our data indicated that this modulatory effect was carried 
out independently of adenylate cyclase and PKA activation, thus indicating some 
reliance on the G protein  or alternative G subunits.  Building upon these results to 
fully elucidate the underlying intracellular mechanism could provide additional 
therapeutic options for manipulating these pathways in a clinical setting.  Nonetheless, 
our studies illustrating the essential downstream role for PI3K in mediating a 
catecholamine-induced M2 macrophage phenotype are in agreement with previous 
reports illustrating its function in similar contexts [18,19].    
 An important mediator involved in the skewing of macrophages towards the M2 
phenotype is IL-10 [1].  We have shown that neutralization of this cytokine negated the 
effects of catecholamines on influencing macrophage polarization in vitro.  Importantly, 
our work also illustrated that the induction of macrophage IL-10 production by 
epinephrine/norepinephrine could not proceed without the concomitant activation of 
TLR4.  This requirement for the simultaneous activation of a TLR and a signaling 
modulator has been demonstrated elsewhere in the context of prostaglandin e2 [20].  
Thus, it is important to note that catecholamines do not directly exert transcriptional 
control over macrophage phenotype determinants, but rather, this effect involves the 
production and secretion of an autocrine/paracrine factor.  While we conclude that the 
catecholamines exert their regulation to limit pro-inflammatory pathways active during 
acute inflammation, we must also carefully consider the context in which these 
hormones are acting.  Although the secretion of catecholamines is enhanced upon an 
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inflammatory stimulus [10], this is also true of many known macrophage phenotype 
regulators.  Thus, understanding how catecholamines fine-tune the immune response to 
limit inflammation will be pivotal in characterizing the immunoregulatory roles of these 
neuroendocrine factors in vivo.  
 To illustrate the protective effects of catecholamines alluded to above, we 
performed in vivo ALI and endotoxemia experiments in the presence and absence of 
the 2 adrenergic receptor inhibitor, ICI 118,551.  Mice receiving the antagonist 
demonstrated severely exacerbated injury levels presumably characterized by distinct 
pathways.  For the LPS-induced ALI model, 2 blockade was accompanied by increased 
epithelial and vascular damage and TNF- production, whereas IL-10 secretion was not 
significantly altered.  Conversely, endotoxemic mice receiving the receptor antagonist 
demonstrated significantly reduced serum IL-10 levels.  While the bases for these 
disparities are unclear, they could be manifested if catecholamines are to differentially 
modulate peritoneal and alveolar macrophage biology in vivo.  Another plausible 
explanation concerns the presence of an alternative pathway by which catecholamines 
could regulate lung injury severity.  Consequently, the characterization of additional 
neuroendocrine targets (e.g., vascular endothelial cells) may provide for novel 
therapeutic developments in the treatment of diseases elicited by pulmonary 
inflammation.  Nonetheless, we have provided substantive evidence for the protective 
role of catecholamines in regulating macrophage phenotype during sepsis.  Specifically, 
we demonstrated that endotoxemic mice adoptively receiving peritoneal macrophages 
pre-treated with LPS and epinephrine in vitro exhibited impressive survival rates.  Thus, 
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it is clear that the induction of an M2-dominated response during sepsis circumvents 
issues arising from excessive inflammation and the resulting tissue damage.  
 Although these experiments suggest a protective role for catecholamines in 
regulating inflammation during the acute phase of sepsis, an interesting clinical question 
arises from their effect in the long term.  Specifically, while septic patients are often 
treated with catecholamines upon the disease’s onset to bolster cardiovascular function, 
mortality often occurs at later time points due to immunosuppression, and in 
consequence, contraction of opportunistic infections.  It remains to be seen whether the 
induction of an M2 phenotype through the administration of 2 adrenergic receptor 
agonists could render septic patients immunocompromised, but with a mortality rate 
ranging from 20% to 30% and a prevalence of about 600,000 cases occurring annually 
in the United States [21,22], it is clear that answering this question could profoundly 
impact clinical survival rates.  Another finding that demands a mechanistic explanation 
comes from van der Poll’s early studies illustrating that catecholamines could inhibit the 
LPS-induced production of IL-1 in human whole blood samples [17].  In a dose-
dependent fashion, increased levels of intracellular cAMP decreased IL-1 production 
from human monocytes, though this was not specifically attributed to an effect brought 
about by catecholamines [17].  It is now known that a large contributor of circulating IL-
1 during endotoxemia comes from an intracellular protein complex called the NLRP3 
inflammasome [23].  This complex becomes activated by microbial endotoxins (among 
other molecules) and cleaves a precursor protein to generate mature IL-1 [23].  While 
it has recently been shown that intracellular cAMP can act to negatively regulate the 
activation of this complex [24], no work has been done to illustrate the effects of 
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catecholamines on its activity during bacterial infections.  These studies could also 
provide an additional seminal discovery concerning the role of catecholamines in 
modulating acute inflammation.   
   In summary, we report an important function for the 2 adrenergic receptor in 
regulating macrophage phenotype.  Specifically, simultaneous activation of the 2 
adrenergic receptor and TLR4 skews macrophages from an LPS-induced M1 
phenotype towards an M2 regulatory macrophage phenotype.  This effect occurs 
through a non-canonical 2 adrenergic receptor signaling pathway with downstream 
dependence on PI3K.  Catecholamines regulate LPS-induced cytokine and phenotype 
marker expression via this signaling mechanism to bring about enhanced IL-10 
production, potentiated arginase-1 expression, and augmented phagocytic activity.  
Consequently, these neuroendocrine factors confer protection during acute 
inflammation by inducing a subsequent Th2-dominated, anti-inflammatory immune 
response.  Much of the data presented herein is included in a report entitled “Induction 
of M2 Regulatory Macrophages through the 2-Adrenergic Receptor with Protection 
during Endotoxemia and Acute Lung Injury” that was recently accepted for publication 
by the Journal of Innate Immunity.    
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